Profile
Graeme Bell is the founder of Valuecycle LLC.
Mr. Bell is currently an Independent Director at Averin Capital Acquisition Corp.
since 2026, a Director at Cytoimmune Therapeutics, Inc. since 2023, a Director at Mindstate Design Labs, Inc. since 2025, and Group Chief Financial Officer at Owkin, Inc. since 2025.
Formerly, Mr. Bell was CEO, Chief Financial & People Officer at Valo Health, Inc. and Valo Health LLC from 2020 to 2024, Director-Investor Relations at Merck & Co., Inc. from 2007 to 2009, Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals LLC from 2015 to 2016, CFO, Principal Accounting Officer & Executive VP at Intellia Therapeutics, Inc. from 2016 to 2018, Chief Financial Officer at Tmunity Therapeutics, Inc. from 2018 to 2020, Director-Claims Development at Uris Group Ltd., and Head-Finance at Organon Pharma (UK) Ltd. Education includes an MBA from the University of Durham.
Graeme Bell active positions
| Companies | Position | Start |
|---|---|---|
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Director/Board Member | 2023-02-28 |
Owkin, Inc.
Owkin, Inc. Packaged SoftwareTechnology Services Develops AI technology that accelerates drug discovery by combining multimodal patient data and large language models | Director of Finance/CFO | 2025-04-30 |
Mindstate Design Labs
Mindstate Design Labs BiotechnologyHealth Technology Operates as preclinical-stage biotechnology company | Director/Board Member | 2025-11-30 |
Former positions of Graeme Bell
| Companies | Position | End |
|---|---|---|
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Chief Executive Officer | 2024-11-17 |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Chief Executive Officer | 2024-11-17 |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Director of Finance/CFO | 2020-05-31 |
| INTELLIA THERAPEUTICS, INC. | Director of Finance/CFO | 2018-08-02 |
| ANACOR PHARMACEUTICALS INC | Director of Finance/CFO | 2016-10-31 |
Training of Graeme Bell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Direct Group Ltd.
Direct Group Ltd. Insurance Brokers/ServicesFinance Provides insurance services | Finance |
University of Durham
University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Health Technology |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Owkin, Inc.
Owkin, Inc. Packaged SoftwareTechnology Services Develops AI technology that accelerates drug discovery by combining multimodal patient data and large language models | Technology Services |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Technology Services |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Health Technology |
Mindstate Design Labs
Mindstate Design Labs BiotechnologyHealth Technology Operates as preclinical-stage biotechnology company | Health Technology |
- Stock Market
- Insiders
- Graeme Bell
















